AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,024 | -7.2% | 151,942 | -5.2% | 0.00% | – |
| Q2 2023 | $381,547 | +267.7% | 160,314 | +184.3% | 0.00% | – |
| Q1 2023 | $103,770 | -42.7% | 56,397 | -40.8% | 0.00% | – |
| Q4 2022 | $180,998 | +92.6% | 95,262 | +116.8% | 0.00% | – |
| Q3 2022 | $94,000 | -51.5% | 43,950 | -35.7% | 0.00% | – |
| Q2 2022 | $194,000 | -73.5% | 68,383 | -61.0% | 0.00% | – |
| Q1 2022 | $731,000 | -9.6% | 175,259 | +12.4% | 0.00% | – |
| Q4 2021 | $809,000 | -36.0% | 155,940 | -19.2% | 0.00% | – |
| Q3 2021 | $1,264,000 | -31.6% | 193,045 | -30.6% | 0.00% | – |
| Q2 2021 | $1,848,000 | +128.1% | 278,264 | +97.0% | 0.00% | – |
| Q1 2021 | $810,000 | -29.9% | 141,226 | +9.3% | 0.00% | – |
| Q4 2020 | $1,155,000 | +178.3% | 129,209 | +262.0% | 0.00% | – |
| Q3 2020 | $415,000 | -71.4% | 35,690 | -60.6% | 0.00% | – |
| Q2 2020 | $1,452,000 | +145100.0% | 90,578 | +335374.1% | 0.00% | – |
| Q1 2019 | $1,000 | – | 27 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
| Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
| MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
| SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
| Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
| Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
| Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
| Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
| Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |